Research Article: Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial
Introduction:
Malignant tumor of liver is one of the most common tumor in the world. An estimated . million new cancer cases and million cancer-related deaths occurred globally in . Liver cancer represents .% of all new malignancies and .% of cancer deaths in the world. Primary liver cancer (PLC) is a lethal disease associated with high morbidity and poor prognosis and always a prerequisite question to be solved in clinical applications. Hepatocellular carcinoma (HCC) accounts for approximately % of all cases of PLC. The…
Read more